EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Uncovering a neurological protein signature for severe COVID-19

Omar El-Agnaf, Ilham Bensmail, Maryam A Y Al-Nesf, James Flynn, Mark Taylor, Nour K Majbour, Ilham Y Abdi, Nishant N Vaikath, Abdulaziz Farooq, Praveen B Vemulapalli, Frank Schmidt, Khalid Ouararhni und 7 weitere

Neurobiology of Disease · 2023

DOI: 10.1016/j.nbd.2023.106147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2023. Verfasst von Omar El-Agnaf und 18 weiteren Autor:innen. Beteiligte Einrichtung: Neurological Disorders Research Center (NDRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doh…. Hauptthemen laut MEDLINE: COVID-19, Nervous System Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hamad Medical Corporation, Qatar Biomedical Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease of 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has sparked a global pandemic with severe complications and high morbidity rate. Neurological symptoms in COVID-19 patients, and neurological sequelae post COVID-19 recovery have been extensively reported. Yet, neurological molecular signature and signaling pathways that are affected in the central nervous system (CNS) of COVID-19 severe patients remain still unknown and need to be identified. Plasma samples from 49 severe COVID-19 patients, 50 mild COVID-19 patients, and 40 healthy controls were subjected to Olink proteomics analysis of 184 CNS-enriched proteins. By using a multi-approach bioinformatics analysis, we identified a 34-neurological protein signature for COVID-19 severity and unveiled dysregulated neurological pathways in severe cases. Here, we identified a new neurological protein signature for severe COVID-19 that was validated in different independent cohorts using blood and postmortem brain samples and shown to correlate with neurological diseases and pharmacological drugs. This protein signature could potentially aid the development of prognostic and diagnostic tools for neurological complications in post-COVID-19 convalescent patients with long term neurological sequelae.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Nervous System DiseasesHumansSARS-CoV-2Central Nervous SystemBrain

Stichwörter der Autor:innen

Neurological complicationsOlink proteomicsProtein signatureSevere COVID-19

Autor:innen und Institutionen

  • Neurological Disorders Research Center (NDRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha, Qatar; College of Health and Life Sciences (CHLS), Hamad Bin Khalif…
  • Proteomics Core Facility, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha, Qatar.
  • Department of Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar; Center of Metabolism and Inflammation, Division of Medicine, Royal Free Campus, University College London, Rowland Hill Road, Londo…
  • Illumina Corporation, San Diego, CA, USA.
  • Bioinfo Solutions LLC, Parker, CO, USA.
  • Neurological Disorders Research Center (NDRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha, Qatar.

Förderung

  • Hamad Medical Corporation
  • Qatar Biomedical Research Institute

Zitieren

APA

El-Agnaf, O., Bensmail, I., Al-Nesf, M. A. Y., Flynn, J., Taylor, M., Majbour, N. K., Abdi, I. Y., Vaikath, N. N., Farooq, A., Vemulapalli, P. B., Schmidt, F., Ouararhni, K., Al-Siddiqi, H. H., Arredouani, A., Wijten, P., Al-Maadheed, M., Mohamed-Ali, V., Decock, J., & Abdesselem, H. B. (2023). Uncovering a neurological protein signature for severe COVID-19. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2023.106147

Vancouver

El-Agnaf O, Bensmail I, Al-Nesf MAY, Flynn J, Taylor M, Majbour NK, et al. Uncovering a neurological protein signature for severe COVID-19. Neurobiology of Disease. 2023. doi:10.1016/j.nbd.2023.106147

BibTeX
@article{ElAgnaf2023,
  author = {El-Agnaf, Omar and Bensmail, Ilham and Al-Nesf, Maryam A Y and Flynn, James and Taylor, Mark and Majbour, Nour K and Abdi, Ilham Y and Vaikath, Nishant N and Farooq, Abdulaziz and Vemulapalli, Praveen B and Schmidt, Frank and Ouararhni, Khalid and Al-Siddiqi, Heba H and Arredouani, Abdelilah and Wijten, Patrick and Al-Maadheed, Mohammed and Mohamed-Ali, Vidya and Decock, Julie and Abdesselem, Houari B},
  title = {Uncovering a neurological protein signature for severe COVID-19},
  journal = {Neurobiology of Disease},
  year = {2023},
  doi = {10.1016/j.nbd.2023.106147}
}
Kostenlos starten →